Aerie Pharmaceuticals reported $-26672000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aerie Pharmaceuticals AERI:US USD -26672000 8.54M
Alimera Sciences ALIM:US USD -3411000 1.44M
Amarin AMRN:US USD 1.43M 39.05M
Bluebird Bio BLUE:US USD -86480000 14.28M
Cara Therapeutics CARA:US USD -23845000 19.37M
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
Horizon Pharma HZNP:US USD 188.16M 41.16M
Insmed INSM:US USD -122459000 21.52M
Merk MRK:US USD 5.56B 156M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Novartis NOVN:VX USD 3.33B 8M
Pacira Pharmaceuticals PCRX:US USD 21.78M 8.6M
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M
Revance Therapeutics RVNC:US USD -77484000 19.64M
Teva Pharmaceutical Industries TEVA:US USD 740M 6M
Valeant Pharmaceuticals VRX:CN USD 378M 92M
Zoetis ZTS:US USD 725M 12M